Kodiak Island Ambulatory Care Clinic INC.

Kodiak Island Ambulatory Care Clinic INC. was paid $2.59M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 63% of everything it billed.

33Billing provider infoKODIAK ISLAND AMBULATORY CARE CLINIC INC.
KODIAK, AK 99615

33aNPI1366596504assigned 01/23/2007

33bProvider typeUrgent Care Clinic/Center

28Total paid$2.59M

24GClaims36,931

24DCodes billed29

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in Alaska

Rank by total paid#3 of 15

Median peer was paid$1.10M

This provider vs. median2.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	6,390	$360K
2019	4,211	$334K
2020	5,738	$406K
2021	8,942	$554K
2022	5,802	$435K
2023	3,112	$252K
2024incomplete	2,736	$247K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	63%	13,839	6,923	$1.63M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	21%	5,842	4,104	$532K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	6.2%	1,080	745	$160K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	4.2%	2,546	1,961	$107K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	2.6%	4,942	2,022	$67K
87807		<1%	1,902	1,536	$21K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	55	48	$19K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	47	45	$9K
0001A		<1%	172	161	$7K
0002A		<1%	165	142	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	425	329	$5K
81001		<1%	1,849	1,171	$4K

17 more codes

99203	Doctor's office visit, new patient (routine)	<1%	27	$4K
92567		<1%	125	$3K
0003A		<1%	50	$2K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	76	$2K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	464	$2K
99490	Ccm add 20min	<1%	155	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	35	$2K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	22	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	451	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	735	$871.86
36415	Collection of venous blood by venipuncture	<1%	661	$660.75
82962		<1%	156	$269.89
85018		<1%	69	$118.58
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	928	$46.92
J7030	Infusion, normal saline solution , 1000 cc	<1%	37	$19.30
85651		<1%	17	$4.27
Q0222	Injection, bebtelovimab, 175 mg	0%	59	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOLLER, JOHN (PRESIDENT)